Crescita Therapeutics Announces Renewal of Normal Course Issuer Bid

Author's Avatar
Dec 15, 2021

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”) announced today that the Toronto Stock Exchange (the “TSX”) has approved the Company’s renewal of its existing normal course issuer bid (“NCIB”) for a portion of its common shares (“Common Shares”) as appropriate opportunities arise from time to time.